🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

US STOCKS-Wall St ends near flat; healthcare shares gain but trade deal delay weighs

Published 06/11/2019, 22:41
Updated 06/11/2019, 22:46
© Reuters.  US STOCKS-Wall St ends near flat; healthcare shares gain but trade deal delay weighs
US500
-
DJI
-
IAC
-
IXIC
-
MTCH
-
SPSY
-
SPNY
-
SPLRCT
-

(For a live blog on the U.S. stock market, click LIVE/ or

type LIVE/ in a news window.)

* Healthcare shares rise

* U.S.-China trade meeting may be delayed until December

* Indexes: Dow near flat, S&P 500 up 0.1%, Nasdaq down 0.3%

(New throughout, updates prices, market activity and comments

to close)

By Caroline Valetkevitch

NEW YORK, Nov 6 (Reuters) - U.S. stocks ended little changed

on Wednesday as a report the U.S.-China trade deal could be

delayed until December was offset by gains in healthcare shares.

The Nasdaq broke a three-day string of record closing highs,

and the Dow barely snapped its two-day run of record highs.

A senior official of the Trump administration told Reuters

a meeting between U.S. President Donald Trump and Chinese

President Xi Jinping to sign a long-awaited interim trade deal

could be delayed until December, as discussions continue over

terms and a venue.

That renewed worries over how long the trade war may

continue and caused stocks to trade lower briefly.

"The big headline was Reuters reporting that the signing of

'phase one' would potentially be pushed into December. The

market sold off on that but nothing major, and right now

investors are in a holding pattern, waiting to see if we set new

highs and can punch through them," said Michael O'Rourke, chief

market strategist at JonesTrading in Greenwich, Connecticut.

The Trump administration official said it was still possible

the "phase one" agreement would not be reached, but a deal was

more likely than not.

The recent rally to record highs had been fueled by signs of

progress in the U.S.-China trade talks along with some upbeat

earnings reports.

On Wednesday, Humana Inc HUM.N rose 3.5% as the health

insurer reported quarterly profit that beat estimates on higher

sales of its government-backed Medicare Advantage health plans.

CVS Health Corp CVS.N gained 5.4% after the pharmacy chain

posted a better-than-expected quarterly profit, boosted by its

Aetna health insurance business and pharmacy benefit management

unit. The S&P health care .SPLRCT was up 0.6%.

The Dow Jones Industrial Average .DJI fell 0.07 points to

27,492.56, the S&P 500 .SPX gained 2.16 points, or 0.07%, to

3,076.78 and the Nasdaq Composite .IXIC dropped 24.05 points,

or 0.29%, to 8,410.63.

Also in health care, DaVita DVA.N shares jumped 12.9%

following its results.

The S&P 500 financials index .SPSY extended recent gains,

rising 0.4%, while the S&P 500 energy index .SPNY fell 2.3%

following declines in oil prices.

Match Group Inc MTCH.O fell 2.5% as the Tinder owner

forecast fourth-quarter revenue below estimates in the face of

stiff competition from rival online dating services. Its parent

firm, IAC/InterActiveCorp IAC.O , dropped 4.3%. Declining issues outnumbered advancing ones on the NYSE by a

1.21-to-1 ratio; on Nasdaq, a 1.76-to-1 ratio favored decliners.

The S&P 500 posted 14 new 52-week highs and 2 new lows; the

Nasdaq Composite recorded 70 new highs and 68 new lows.

Volume on U.S. exchanges was 7.93 billion shares, compared

to the 6.74 billion average for the full session over the last

20 trading days.

(Editing by Chris Reese, Jonathan Oatis and David Gregorio)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.